Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.20.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 5,437 $ 5,789
Restricted cash 312 312
Accounts receivable, less allowance of $3,581 and $2,531 in 2020 and 2019, respectively 4,119 8,760
Inventory 11,932 10,995
Prepaid expenses and other current assets 1,094 1,163
Total current assets 22,894 27,019
Property, plant, and equipment, net 781 1,193
Goodwill 2,926 2,926
Right of use asset 649 276
Other assets 506 433
Total assets 27,756 31,847
Current liabilities:    
Accounts payable 2,510 5,332
Accrued liabilities 3,549 4,744
Deferred revenue, current portion 1,486 2,237
Term loan (net of discount) 13,544 13,466
Total current liabilities 21,089 25,779
Deferred revenue 412 358
Warranty accrual 194 245
Non current term loans 3,140  
Other liabilities 1,612 1,123
Total liabilities 26,447 27,505
Commitments and contingencies — Note 11
Redeemable preferred stock:    
Preferred stock, par value $0.001 per share; 1,000 shares authorized, 0 and 70 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively   3,965
Stockholders' equity:    
Common stock, par value $0.001 per share; 180,000 and 40,000 shares authorized, 50,387 and 31,439 shares issued and 50,342 and 31,439 outstanding as of June 30, 2020 and December 31, 2019, respectively 50 31
Additional paid-in-capital 247,155 235,594
Accumulated other comprehensive loss (645) (701)
Accumulated deficit (245,251) (234,547)
Total stockholders' equity 1,309 377
Total liabilities, redeemable preferred stock and stockholders' equity $ 27,756 $ 31,847